ATE356549T1 - Verfahren zur inaktivierung von bakterien mit einbegriff von bakteriensporen - Google Patents
Verfahren zur inaktivierung von bakterien mit einbegriff von bakteriensporenInfo
- Publication number
- ATE356549T1 ATE356549T1 AT98964997T AT98964997T ATE356549T1 AT E356549 T1 ATE356549 T1 AT E356549T1 AT 98964997 T AT98964997 T AT 98964997T AT 98964997 T AT98964997 T AT 98964997T AT E356549 T1 ATE356549 T1 AT E356549T1
- Authority
- AT
- Austria
- Prior art keywords
- bacterial spores
- including bacterial
- inactivation
- bacteria including
- oil
- Prior art date
Links
- 241000894006 Bacteria Species 0.000 title abstract 3
- 210000004666 bacterial spore Anatomy 0.000 title abstract 2
- 230000002779 inactivation Effects 0.000 title 1
- 239000007764 o/w emulsion Substances 0.000 abstract 2
- 241000193830 Bacillus <bacterium> Species 0.000 abstract 1
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- 230000000415 inactivating effect Effects 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
- A01N25/04—Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/12—Iodine, e.g. iodophors; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Agronomy & Crop Science (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/002,228 US6015832A (en) | 1997-12-31 | 1997-12-31 | Methods of inactivating bacteria including bacterial spores |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE356549T1 true ATE356549T1 (de) | 2007-04-15 |
Family
ID=21699801
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98964997T ATE356549T1 (de) | 1997-12-31 | 1998-12-28 | Verfahren zur inaktivierung von bakterien mit einbegriff von bakteriensporen |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6015832A (de) |
| EP (1) | EP1041978B1 (de) |
| JP (1) | JP4683724B2 (de) |
| AT (1) | ATE356549T1 (de) |
| AU (1) | AU749817B2 (de) |
| CA (1) | CA2316888C (de) |
| DE (1) | DE69837348T2 (de) |
| IL (1) | IL137093A (de) |
| WO (1) | WO1999033459A1 (de) |
Families Citing this family (100)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6524592B2 (en) * | 1997-10-17 | 2003-02-25 | American Home Products Corporation | Veterinary vaccines |
| US7390432B2 (en) * | 1998-06-30 | 2008-06-24 | Sandia Corporation | Enhanced formulations for neutralization of chemical, biological and industrial toxants |
| US6723890B2 (en) | 1998-06-30 | 2004-04-20 | Sandia Corporation | Concentrated formulations and methods for neutralizing chemical and biological toxants |
| US6635676B2 (en) * | 1999-04-28 | 2003-10-21 | Regents Of The University Of Michigan | Non-toxic antimicrobial compositions and methods of use |
| US6559189B2 (en) | 1999-04-28 | 2003-05-06 | Regents Of The University Of Michigan | Non-toxic antimicrobial compositions and methods of use |
| US7767216B2 (en) * | 1999-04-28 | 2010-08-03 | The Regents Of The University Of Michigan | Antimicrobial compositions and methods of use |
| US6506803B1 (en) * | 1999-04-28 | 2003-01-14 | Regents Of The University Of Michigan | Methods of preventing and treating microbial infections |
| US7655252B2 (en) * | 1999-04-28 | 2010-02-02 | The Regents Of The University Of Michigan | Antimicrobial nanoemulsion compositions and methods |
| US20030059839A1 (en) * | 2001-05-22 | 2003-03-27 | Obiso Richard J. | Method for detecting pathogens using immunoassays |
| EP2545937A1 (de) * | 2001-06-05 | 2013-01-16 | The Regents Of The University Of Michigan | Nanoemulsionsimpfstoffe |
| JP2010209109A (ja) * | 2001-06-25 | 2010-09-24 | Regents Of The Univ Of Michigan | 抗微生物ナノエマルジョンの組成物および方法 |
| CA2463710A1 (en) * | 2001-10-19 | 2003-05-15 | David S. Soane | Anti-pathogenic air filtration media and air handling devices having protective capabilities against infectious airborne microorganisms |
| AU2002366444A1 (en) * | 2001-11-08 | 2003-09-09 | Merck & Co., Inc. | Compounds useful in the treatment of anthrax |
| US20040087564A1 (en) * | 2002-10-31 | 2004-05-06 | Wright D. Craig | Delivery composition and method |
| US20050208083A1 (en) | 2003-06-04 | 2005-09-22 | Nanobio Corporation | Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof |
| US8211448B2 (en) | 2003-07-07 | 2012-07-03 | Nares Ab | Microemulsions and its use for preventing airway diseases |
| DE602004010130T2 (de) * | 2003-07-07 | 2008-09-18 | Nares Ab | Mikroemulsionen und ihre verwendung zur prävention von erkrankungen der atemwege |
| US20050100601A1 (en) * | 2003-11-07 | 2005-05-12 | Viratox, L.L.C. | Virucidal activities of cetylpyridinium chloride |
| WO2006076334A1 (en) * | 2005-01-11 | 2006-07-20 | Clean Earth Technologies, Llc | Peracid/ peroxide composition and use thereof as an anti-microbial and a photosensitizer |
| EP1871349A1 (de) * | 2005-04-11 | 2008-01-02 | Nanobio Corporation | Quartäre ammoniumhalogenide zur behandlung von infektionskrankheiten |
| JP2009504805A (ja) * | 2005-08-09 | 2009-02-05 | ナノバイオ コーポレーション | 抗炎症活性を有するナノエマルジョン組成物 |
| US7797337B2 (en) * | 2005-09-29 | 2010-09-14 | Scenera Technologies, Llc | Methods, systems, and computer program products for automatically associating data with a resource as metadata based on a characteristic of the resource |
| US9839685B2 (en) * | 2006-04-13 | 2017-12-12 | The Regents Of The University Of Michigan | Methods of inducing human immunodeficiency virus-specific immune responses in a host comprising nasally administering compositions comprising a naonemulsion and recombinant GP120 immunogen |
| CA2649457A1 (en) * | 2006-04-13 | 2007-10-25 | The Regents Of The University Of Michigan | Nanoemulsion vaccines |
| US20080038295A1 (en) * | 2006-04-13 | 2008-02-14 | Regents Of The University Of Michigan | Compositions and methods for orthopox virus vaccination |
| US10138279B2 (en) | 2006-04-13 | 2018-11-27 | Regents Of The University Of Michigan | Compositions and methods for Bacillus anthracis vaccination |
| WO2008103416A1 (en) * | 2007-02-21 | 2008-08-28 | Capps Charles L | Synergistic enhancement of calcium propionate |
| EP2152304B1 (de) | 2007-05-02 | 2018-08-22 | The Regents of the University of Michigan | Therapeutische zusammensetzungen in nanoemulsionsform und anwendungsverfahren dafür |
| JP2011518184A (ja) * | 2008-04-18 | 2011-06-23 | ナノバイオ コーポレーション | ヘルペスウイルス感染の治療方法 |
| CA2721800A1 (en) | 2008-04-21 | 2009-10-29 | Nanobio Corporation | Nanoemulsion influenza vaccine |
| US8226965B2 (en) * | 2008-04-25 | 2012-07-24 | Nanobio Corporation | Methods of treating fungal, yeast and mold infections |
| WO2009132343A1 (en) * | 2008-04-25 | 2009-10-29 | Nanobio Corporation | Nanoemulsions for treating onchomycosis |
| EP2293814A4 (de) * | 2008-05-23 | 2013-02-13 | Univ Michigan | Nanoemulsionshilfsstoffe |
| US8877208B2 (en) | 2008-05-23 | 2014-11-04 | The Regents Of The University Of Michigan | Multivalent nanoemulsion vaccines |
| WO2010036945A2 (en) * | 2008-09-26 | 2010-04-01 | The Regents Of The University Of Michigan | Nanoemulsion therapeutic compositions and methods of using the same |
| CN102202672A (zh) | 2008-10-10 | 2011-09-28 | 达拉生物科学公司 | 使用穗霉素衍生物治疗或预防疼痛的方法 |
| US20100160224A1 (en) * | 2008-10-14 | 2010-06-24 | David Thomas | Shelf-stable consumable compositions containing probiotic-mimicking elements and methods of preparing and using the same |
| CA2743904A1 (en) | 2008-11-17 | 2010-05-20 | The Regents Of The University Of Michigan | Cancer vaccine compositions and methods of using the same |
| EP2391342A2 (de) | 2009-01-28 | 2011-12-07 | Nanobio Corporation | Zusammensetzungen für behandlung und prophylaxe von akne, verfahren zur herstellung der zusammensetzungen und verwendungsverfahren dafür |
| WO2010132833A1 (en) | 2009-05-14 | 2010-11-18 | The Regents Of The University Of Michigan | Streptococcus vaccine compositions and methods of using the same |
| RU2585961C9 (ru) | 2009-05-22 | 2016-12-27 | Дженосеа Биосайенсиз Инк. | Вакцины против вируса простого герпеса 2 типа: композиции и способы запуска иммунного ответа |
| EP3020412B1 (de) | 2009-06-16 | 2017-10-11 | The Regents of the University of Michigan | Nanoemulsionsimpfstoffe |
| WO2011116262A2 (en) * | 2010-03-19 | 2011-09-22 | The Regents Of The University Of Michigan | Compositions and methods for diagnosing and treating urinary tract infections |
| CA2840982C (en) | 2011-07-06 | 2022-06-07 | Vira BITKO | Human respiratory syncytial virus vaccine |
| JP6205360B2 (ja) | 2011-08-22 | 2017-09-27 | ナノバイオ コーポレーション | 単純ヘルペスウイルスのナノエマルジョンワクチン |
| EP2753354A4 (de) | 2011-09-09 | 2015-04-15 | Nanobio Corp | Untereinheitsimpfstoff in nanoemulsionsform für das respiratorische synzytialvirus |
| JP6199878B2 (ja) | 2011-11-23 | 2017-09-20 | ジェノセア バイオサイエンシーズ, インコーポレイテッド | 単純ヘルペスウイルス2型に対する核酸ワクチン:免疫応答を誘発する組成物及び方法 |
| EP4112076A1 (de) | 2014-10-10 | 2023-01-04 | The Regents of The University of Michigan | Nanoemulsionszusammensetzungen zur prävention, unterdrückung oder eliminierung von allergischen und entzündlichen erkrankungen |
| US20180344817A1 (en) | 2015-05-01 | 2018-12-06 | Precision Biosciences, Inc. | Precise deletion of chromosomal sequences in vivo and treatment of nucleotide repeat expansion disorders using engineered nucleases |
| US11173197B2 (en) | 2015-07-07 | 2021-11-16 | Bluewillow Biologics, Inc. | Methods and compositions for nanoemulsion vaccine formulations |
| CA2997909A1 (en) | 2015-09-08 | 2017-03-16 | Precision Biosciences, Inc. | Treatment of retinitis pigmentosa using engineered meganucleases |
| ES2803728T3 (es) | 2015-10-05 | 2021-01-29 | Prec Biosciences Inc | Células genéticamente modificadas que comprenden un gen de región constante alfa del receptor de linfocitos T humano modificado |
| ES2768984T3 (es) | 2015-10-05 | 2020-06-24 | Prec Biosciences Inc | Meganucleasas diseñadas con secuencias de reconocimiento encontradas en el gen de la región constante alfa del receptor de células T humanas |
| US20190017075A1 (en) | 2015-12-23 | 2019-01-17 | Precision Biosciences, Inc. | Engineered meganucleases with recognition sequences found in the human beta-2 microglobulin gene |
| EP3448380B1 (de) | 2016-04-27 | 2021-12-01 | University Of Puerto Rico | 1,5-disubstituierte 1,2,3-triazole als hemmer von rac/cdc42-gtpasen |
| EP3452583B1 (de) | 2016-05-03 | 2021-10-27 | Precision Biosciences, Inc. | Manipulierte nukleasen zur behandlung von hämophilie a |
| EP3454891A4 (de) | 2016-05-10 | 2019-12-25 | The Regents of The University of Michigan | Emulsionsadjuvans zur intramuskulären, intradermalen und subkutanen verabreichung |
| WO2017201390A1 (en) | 2016-05-19 | 2017-11-23 | The Regents Of The University Of Michigan | Novel adjuvant compositions |
| EP3519427A4 (de) | 2016-09-28 | 2020-03-11 | Genocea Biosciences Inc. | Verfahren und zusammensetzungen zur behandlung von herpes |
| DK3757120T3 (da) | 2016-10-04 | 2022-07-25 | Prec Biosciences Inc | Co-stimulerende domæner til anvendelse i genetisk modificerede celler |
| KR20230010826A (ko) | 2016-10-14 | 2023-01-19 | 프리시젼 바이오사이언시스 인코포레이티드 | B형 간염 바이러스 게놈 내의 인식 서열에 대해 특이적인 조작된 메가뉴클레아제 |
| WO2018073393A2 (en) | 2016-10-19 | 2018-04-26 | Cellectis | Tal-effector nuclease (talen) -modified allogenic cells suitable for therapy |
| EP4269596A3 (de) | 2017-04-21 | 2024-02-14 | Precision Biosciences, Inc. | Für erkennungssequenzen im pcsk9-gen spezifische manipulierte meganukleasen |
| US20200190541A1 (en) | 2017-04-28 | 2020-06-18 | Precision Biosciences, Inc. | Methods for reducing dna-induced cytotoxicity and enhancing gene editing in primary cells |
| JP7170666B2 (ja) | 2017-05-08 | 2022-11-14 | プレシジョン バイオサイエンシズ,インク. | 操作された抗原受容体をコードする核酸分子及び阻害性核酸分子、並びにそれらの使用方法 |
| EP4775669A2 (de) | 2017-06-30 | 2026-07-15 | Precision Biosciences, Inc. | Genetisch modifizierte t-zellen mit einem modifizierten intron im t-zell-rezeptor-alpha-gen |
| WO2019046254A1 (en) * | 2017-08-28 | 2019-03-07 | University Of Louisiana At Lafayette | METHOD FOR MANUFACTURING HAND DISINFECTANT LOTION HAVING EXTENDED EFFICACY AND COMPOSITION OF MATERIAL OBTAINED |
| EP3692057B9 (de) | 2017-10-03 | 2023-10-04 | Precision BioSciences, Inc. | Modifizierte epidermale wachstumsfaktorrezeptorpeptide zur verwendung in genetisch modifizierten zellen |
| EP3704238B1 (de) | 2017-11-01 | 2024-01-03 | Precision Biosciences, Inc. | Gegen humane und canine faktor-viii-gene gerichtete manipulierte nukleasen als behandlung für hämophilie a |
| KR102617818B1 (ko) | 2018-04-12 | 2023-12-27 | 프리시젼 바이오사이언시스 인코포레이티드 | 인간 t 세포 수용체 알파 불변 영역 유전자에 대한 특이성을 갖는 최적화된 조작된 뉴클레아제 |
| US11142750B2 (en) | 2018-04-12 | 2021-10-12 | Precision Biosciences, Inc. | Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome |
| JP7642536B2 (ja) | 2018-11-15 | 2025-03-10 | ブルーウィロー バイオロジクス、インコーポレイテッド | 強化された透過性を有するナノエマルジョン組成物 |
| US11369578B2 (en) | 2018-11-15 | 2022-06-28 | Bluewillow Biologics, Inc. | Persistent topical antimicrobial compositions and methods of using the same |
| EP3898661A1 (de) | 2018-12-21 | 2021-10-27 | Precision BioSciences, Inc. | Genetische modifikation des hydroxysäure-oxidase-1-gens zur behandlung von primärer hyperoxalurie |
| EP4332115A3 (de) | 2019-04-03 | 2024-05-29 | Precision Biosciences, Inc. | Genetisch modifizierte immunzellen mit einer mikrorna-adaptierten shrna (shrnamir) |
| US20220273715A1 (en) | 2019-07-25 | 2022-09-01 | Precision Biosciences, Inc. | Compositions and methods for sequential stacking of nucleic acid sequences into a genomic locus |
| WO2021035054A1 (en) | 2019-08-20 | 2021-02-25 | Precision Biosciences, Inc. | Lymphodepletion dosing regimens for cellular immunotherapies |
| US20220411479A1 (en) | 2019-10-30 | 2022-12-29 | Precision Biosciences, Inc. | Cd20 chimeric antigen receptors and methods of use for immunotherapy |
| US12410418B2 (en) | 2019-12-06 | 2025-09-09 | Precision Biosciences, Inc. | Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome |
| EP4069285A1 (de) | 2019-12-06 | 2022-10-12 | Precision BioSciences, Inc. | Methoden zur krebsimmuntherapie unter verwendung von lymphodepletionsregimen und allogenen cd19-, cd20- oder bcma-car-t-zellen |
| WO2021231259A1 (en) | 2020-05-11 | 2021-11-18 | Precision Biosciences, Inc. | Self-limiting viral vectors encoding nucleases |
| EP4150068A1 (de) | 2020-05-12 | 2023-03-22 | Precision BioSciences, Inc. | Behandlung von retinitis pigmentosa mit verbesserten manipulierten meganukleasen |
| EP4192875A1 (de) | 2020-08-10 | 2023-06-14 | Precision BioSciences, Inc. | Antikörper und fragmente spezifisch für b-zellreifungsantigen und verwendungen davon |
| MY202052A (en) * | 2020-08-14 | 2024-03-30 | Univ Putra Malaysia | Nano emulsion composition having antimicrobial properties |
| US20240011003A1 (en) | 2020-08-21 | 2024-01-11 | Precision Biosciences, Inc. | Engineered meganucleases having specificity for a recognition sequence in the transthyretin gene |
| KR20250099412A (ko) | 2020-11-12 | 2025-07-01 | 프리시젼 바이오사이언시스 인코포레이티드 | 디스트로핀 유전자 내의 인식 서열에 대해 특이성을 갖는 조작된 메가뉴클레아제 |
| CA3172161A1 (en) | 2021-01-08 | 2022-07-14 | James Jefferson Smith | Engineered meganucleases having specificity for a recognition sequence in the hydroxyacid oxidase 1 gene |
| WO2022165111A1 (en) | 2021-01-28 | 2022-08-04 | Precision Biosciences, Inc. | Modulation of tgf beta signaling in genetically-modified eukaryotic cells |
| US20240200046A1 (en) | 2021-04-22 | 2024-06-20 | Precision Biosciences, Inc. | Engineered meganucleases that target human mitochondrial genomes |
| IL307834A (en) | 2021-04-22 | 2023-12-01 | Prec Biosciences Inc | Transgenic meganonucleases targeting human mitochondrial genomes |
| AU2022368911A1 (en) | 2021-10-19 | 2024-05-30 | Precision Biosciences, Inc. | Gene editing methods for treating alpha-1 antitrypsin (aat) deficiency |
| MX2024004812A (es) | 2021-10-19 | 2024-07-15 | Prec Biosciences Inc | Métodos de edición génica para el tratamiento de la deficiencia de alfa-1 antitripsina (aat). |
| WO2023081767A1 (en) | 2021-11-05 | 2023-05-11 | Precision Biosciences, Inc. | Methods for immunotherapy |
| IL321936A (en) | 2023-01-05 | 2025-09-01 | Prec Biosciences Inc | Optimized engineered meganucleases with specificity for the human T-cell receptor alpha constant region gene |
| WO2024216116A1 (en) | 2023-04-14 | 2024-10-17 | Precision Biosciences, Inc. | Muscle-specific expression cassettes |
| CN121311497A (zh) | 2023-04-14 | 2026-01-09 | 精密生物科学公司 | 肌肉特异性表达盒 |
| WO2025101946A1 (en) | 2023-11-08 | 2025-05-15 | Precision Biosciences, Inc. | Polypeptide linkers for use in engineered meganucleases |
| WO2025233894A1 (en) | 2024-05-09 | 2025-11-13 | University Of Miami | Engineered meganucleases that target human mitochondrial genomes |
| WO2026028165A1 (en) | 2024-08-01 | 2026-02-05 | Precision Biosciences, Inc. | Engineered meganucleases having specificity for recognition sequences in the c9orf72 gene |
| CN119908386A (zh) * | 2024-12-26 | 2025-05-02 | 合肥工业大学 | 一种芽孢的杀灭方法和应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4020183A (en) * | 1974-12-03 | 1977-04-26 | Ortho Pharmaceutical Corporation | Nonionic surface active anti-herpes simplex viral agents |
| US4412985A (en) * | 1980-10-06 | 1983-11-01 | Edward Shanbrom | Depyrogenation process |
| US4540573A (en) * | 1983-07-14 | 1985-09-10 | New York Blood Center, Inc. | Undenatured virus-free biologically active protein derivatives |
| US4909940A (en) * | 1987-12-30 | 1990-03-20 | New York Blood Center, Inc. | Extraction of process chemicals from labile biological mixtures with organic alcohols or with halogenated hydrocarbons |
| ATE101490T1 (de) * | 1988-06-22 | 1994-03-15 | Applied Microbiology Inc | Nisin-zusammensetzungen zur anwendung als erhoehte breit-spektrum-bakterizide. |
| US5156973A (en) * | 1988-11-23 | 1992-10-20 | Edward Shanbrom | Antiviral blood sampling process and apparatus |
| JP3628343B2 (ja) * | 1993-11-01 | 2005-03-09 | 亘起物産有限会社 | ウィルス不活化剤 |
| JPH07196408A (ja) * | 1993-12-28 | 1995-08-01 | Amano Pharmaceut Co Ltd | 抗菌性組成物 |
| AU687562B2 (en) * | 1994-05-20 | 1998-02-26 | Novavax, Inc. | Antimicrobial oil-in-water emulsions |
| US5549901A (en) * | 1994-05-20 | 1996-08-27 | Novavax, Inc. | Antimicrobial oil-in-water emulsions |
| US5547677A (en) * | 1994-05-20 | 1996-08-20 | Novavax, Inc. | Antimicrobial oil-in-water emulsions |
| US6034073A (en) * | 1995-04-24 | 2000-03-07 | Novavax, Inc. | Solvent detergent emulsions having antiviral activity |
| JP2868206B2 (ja) * | 1996-04-16 | 1999-03-10 | 株式会社オフテクス | 消毒および/または防腐のための有害微生物防除用組成物 |
-
1997
- 1997-12-31 US US09/002,228 patent/US6015832A/en not_active Expired - Lifetime
-
1998
- 1998-12-28 CA CA002316888A patent/CA2316888C/en not_active Expired - Lifetime
- 1998-12-28 EP EP98964997A patent/EP1041978B1/de not_active Expired - Lifetime
- 1998-12-28 IL IL137093A patent/IL137093A/en not_active IP Right Cessation
- 1998-12-28 WO PCT/US1998/027755 patent/WO1999033459A1/en not_active Ceased
- 1998-12-28 DE DE69837348T patent/DE69837348T2/de not_active Expired - Lifetime
- 1998-12-28 JP JP2000526216A patent/JP4683724B2/ja not_active Expired - Lifetime
- 1998-12-28 AU AU20198/99A patent/AU749817B2/en not_active Expired
- 1998-12-28 AT AT98964997T patent/ATE356549T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IL137093A0 (en) | 2001-06-14 |
| DE69837348T2 (de) | 2007-11-29 |
| JP2001527041A (ja) | 2001-12-25 |
| WO1999033459A1 (en) | 1999-07-08 |
| EP1041978A1 (de) | 2000-10-11 |
| AU2019899A (en) | 1999-07-19 |
| HK1031839A1 (en) | 2001-06-29 |
| CA2316888A1 (en) | 1999-07-08 |
| JP4683724B2 (ja) | 2011-05-18 |
| EP1041978A4 (de) | 2004-05-19 |
| US6015832A (en) | 2000-01-18 |
| AU749817B2 (en) | 2002-07-04 |
| EP1041978B1 (de) | 2007-03-14 |
| IL137093A (en) | 2007-03-08 |
| DE69837348D1 (de) | 2007-04-26 |
| CA2316888C (en) | 2007-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69837348D1 (de) | Verfahren zur inaktivierung von bakterien mit einbegriff von bakteriensporen | |
| DE69432351D1 (de) | Verfahren zum sterilisieren von produkten | |
| DE3280150D1 (de) | Mikroorganismen fuer den mikrobiellen abbau von schaedlichen organischen abfallstoffen in unschaedliche materialien. | |
| DE69910790D1 (de) | Bakterien als mittel für teppiche zur unterdrückung von schlechten gerüchen | |
| ATE201906T1 (de) | Zusammenwetzungen und verfahren zur entgiftung von zearalenon | |
| DE69233041D1 (de) | Behandlung von amplifizierter DNS mit alkalischer Phosphatase | |
| BG101748A (en) | Heterocyclic condensated pyridines | |
| DE69841437D1 (de) | Bakterielle impfstoffe, enthaltend auxotrophe attenuierte listerienstämme, welche heterologe antigene exprimieren | |
| ATE263253T1 (de) | Nachweis von bakterien und bakteriophagen mit immobilisierten enzymsubstraten | |
| DE59712134D1 (de) | Injektionsformulierungen von avermectinen und milbemycinen auf basis von rizinusöl | |
| ATE183616T1 (de) | Zusammensetzung und verfahren zur bekämpfung von pflanzenkrankheiten | |
| TR199901136T2 (xx) | Beauverisin zehir giderme bile�ikleri ve y�ntemleri. | |
| DE69811709D1 (de) | Bekämpfungsmittel gegen pflanzenpathogene mikro-organismen | |
| MX9303594A (es) | Oximas piridino, pirrolidino y azepino substituidas utiles como agentes antiateroscleroticos y antihipercolesterolemicos. | |
| ATE149367T1 (de) | Chemisch-biologisches verfahren zur dehalogenierung von halogenierten organischen verbindungen | |
| DE69834116D1 (de) | Kulturmedium für den nachweis von bakterieller pathogene der gattung listeria, sowie verfahren zur identifizierung von dieser bakterien | |
| ATE245995T1 (de) | Medikament, insbesondere zur modulation der immunantwort bei der bekämpfung von viren, tumoren, bakterien und parasiten | |
| DE69917061D1 (de) | Nitrocumarine für den nachweis aller mikroorganismen | |
| ATE242336T1 (de) | Verfahren zur vebesserung des wachstums und des kolorimetrischen nachweises von bakterien, hefen, pilzen oder kokken | |
| ATE188203T1 (de) | Verbesserter biologischer abbau von organischen abfällen | |
| ATE265143T1 (de) | Verfahren zur bekämpfung von mikroorganismen | |
| DE69027115D1 (de) | Verfahren und mittel zur mikrobiologischen sanierung von verunreinigtem boden und mikroorganismen zur verwendung in diesem verfahren | |
| DE69938774D1 (de) | Verfahren zur isolierung, amplifizierung und charakterisierung von dns | |
| DE59000468D1 (de) | Verfahren zur schnellen pruefung der wirksamkeit von agenzien auf mikroorganismen. | |
| ATE213782T1 (de) | Verfahren zur biotransformation von colchicinoid- verbindungen in die entsprechenden 3- glycosylderivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |